Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs

Listen to Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, as they answer audience questions from a live webinar about how to best use the plethora of active agents and regimens now available for patients with advanced multiple myeloma.